Skip to main content
. 1999 Oct 25;1999(4):CD002080. doi: 10.1002/14651858.CD002080

Muraro 1995.

Methods Randomized, parallel, single‐blind, 
 controlled study.
Participants N=20; 
 Geographic region: Italy 
 Mean age: 42.5 
 Discontinuations/Not available to follow‐up: none reported
Interventions Seaprose S (a proteolytic enzyme reported to have anti‐inflammatory action) 30 mg + hyperthermia (combo)(n=10) vs. Hyperthermia (mono) [1 hr session x 7 each; 42.5 ‐ 43.5C] (n=10). 
 Study duration: 2 weeks
Outcomes Symptomatic changes; Instrumental tests (uroflowmetry; transurethral prostatic echography).
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear